Grace Therapeutics (GRCE) Competitors $3.80 -0.08 (-2.06%) (As of 12/18/2024 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends GRCE vs. GOSS, NBTX, ACTU, MCRB, ATOS, RPTX, TELO, ENTA, IFRX, and SGMTShould you be buying Grace Therapeutics stock or one of its competitors? The main competitors of Grace Therapeutics include Gossamer Bio (GOSS), Nanobiotix (NBTX), Actuate Therapeutics (ACTU), Seres Therapeutics (MCRB), Atossa Therapeutics (ATOS), Repare Therapeutics (RPTX), Telomir Pharmaceuticals (TELO), Enanta Pharmaceuticals (ENTA), InflaRx (IFRX), and Sagimet Biosciences (SGMT). These companies are all part of the "pharmaceutical preparations" industry. Grace Therapeutics vs. Gossamer Bio Nanobiotix Actuate Therapeutics Seres Therapeutics Atossa Therapeutics Repare Therapeutics Telomir Pharmaceuticals Enanta Pharmaceuticals InflaRx Sagimet Biosciences Gossamer Bio (NASDAQ:GOSS) and Grace Therapeutics (NASDAQ:GRCE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations. Does the media favor GOSS or GRCE? In the previous week, Gossamer Bio's average media sentiment score of 0.00 equaled Grace Therapeutics'average media sentiment score. Company Overall Sentiment Gossamer Bio Neutral Grace Therapeutics Neutral Do analysts rate GOSS or GRCE? Gossamer Bio currently has a consensus price target of $9.20, suggesting a potential upside of 1,044.14%. Given Gossamer Bio's stronger consensus rating and higher possible upside, analysts clearly believe Gossamer Bio is more favorable than Grace Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gossamer Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Grace Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, GOSS or GRCE? Grace Therapeutics has lower revenue, but higher earnings than Gossamer Bio. Grace Therapeutics is trading at a lower price-to-earnings ratio than Gossamer Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGossamer Bio$105.32M1.73-$179.82M-$0.32-2.51Grace TherapeuticsN/AN/A-$12.85M-$1.01-3.76 Does the MarketBeat Community favor GOSS or GRCE? Gossamer Bio received 151 more outperform votes than Grace Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformGossamer BioOutperform Votes15166.23% Underperform Votes7733.77% Grace TherapeuticsN/AN/A Which has more risk & volatility, GOSS or GRCE? Gossamer Bio has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Grace Therapeutics has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Do insiders and institutionals believe in GOSS or GRCE? 81.2% of Gossamer Bio shares are held by institutional investors. Comparatively, 6.1% of Grace Therapeutics shares are held by institutional investors. 5.0% of Gossamer Bio shares are held by insiders. Comparatively, 13.5% of Grace Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is GOSS or GRCE more profitable? Grace Therapeutics' return on equity of -18.09% beat Gossamer Bio's return on equity.Company Net Margins Return on Equity Return on Assets Gossamer BioN/A -127.28% -22.12% Grace Therapeutics N/A -18.09%-15.38% SummaryGossamer Bio beats Grace Therapeutics on 9 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Grace Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRCE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRCE vs. The Competition Export to ExcelMetricGrace TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.53M$6.72B$5.03B$8.96BDividend YieldN/A3.07%4.80%4.06%P/E Ratio-3.7610.40134.2116.92Price / SalesN/A187.361,128.89116.20Price / CashN/A57.1640.5137.93Price / Book0.585.194.734.71Net Income-$12.85M$151.85M$118.37M$225.20M7 Day Performance-2.56%-5.30%12.07%-2.58%1 Month PerformanceN/A-4.64%9.95%3.57%1 Year PerformanceN/A9.44%30.10%16.54% Grace Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRCEGrace TherapeuticsN/A$3.80-2.1%N/AN/A$38.53MN/A-3.76N/AHigh Trading VolumeGOSSGossamer Bio3.6549 of 5 stars$0.71-4.0%$9.20+1,191.0%-5.9%$161.48M$105.32M-2.23180NBTXNanobiotix1.6392 of 5 stars$3.40+3.3%$12.00+252.9%-43.6%$160.25M$36.22M0.00100News CoverageGap UpHigh Trading VolumeACTUActuate TherapeuticsN/A$7.97-4.9%N/AN/A$155.67MN/A0.0010MCRBSeres Therapeutics3.6128 of 5 stars$0.90-3.2%$5.08+464.8%-23.9%$153.67M$126.32M-3.93233Gap UpATOSAtossa Therapeutics1.5659 of 5 stars$1.22-3.2%$7.00+473.8%+37.5%$153.48MN/A-5.558Short Interest ↓RPTXRepare Therapeutics3.4098 of 5 stars$3.60+19.6%$10.00+177.8%-80.4%$153.04M$66.52M-1.65180High Trading VolumeTELOTelomir PharmaceuticalsN/A$5.10-8.6%N/AN/A$151.01MN/A0.001High Trading VolumeENTAEnanta Pharmaceuticals4.416 of 5 stars$7.00-19.0%$19.50+178.6%-34.6%$148.33M$67.64M-1.28145High Trading VolumeIFRXInflaRx1.8827 of 5 stars$2.51+0.4%$8.00+218.7%+53.2%$147.80M$168,498.00-2.4960Positive NewsHigh Trading VolumeSGMTSagimet Biosciences2.4136 of 5 stars$4.71-3.7%$23.00+388.3%-8.7%$144.48M$2M0.008Gap Up Related Companies and Tools Related Companies Gossamer Bio Alternatives Nanobiotix Alternatives Actuate Therapeutics Alternatives Seres Therapeutics Alternatives Atossa Therapeutics Alternatives Repare Therapeutics Alternatives Telomir Pharmaceuticals Alternatives Enanta Pharmaceuticals Alternatives InflaRx Alternatives Sagimet Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GRCE) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
